---
title: "Akero Therapeutics CEO Cheng Andrew Sells 30,000 Shares"
date: "2025-02-12 10:40:02"
summary: "Reporter NameCheng AndrewRelationshipPresident and CEOTypeSellAmount$1,581,994SEC FilingForm 4Akero Therapeutics President and CEO, Cheng Andrew, reported selling 30,000 shares of Common Stock on February 10, 2025, under a Rule 10b5-1 trading plan. The sales were conducted at weighted average prices ranging from $51.752 to $55.81, totaling $1,581,994. Following these transactions, Cheng directly..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Cheng Andrew |
| --- | --- |
| Relationship | President and CEO |
| Type | Sell |
| Amount | $1,581,994 |
| SEC Filing | [Form 4](https://www.sec.gov/Archives/edgar/data/1778307/000095017025018311/xslF345X05/ownership.xml) |

Akero Therapeutics President and CEO, Cheng Andrew, reported selling 30,000 shares of Common Stock on February 10, 2025, under a Rule 10b5-1 trading plan. The sales were conducted at weighted average prices ranging from $51.752 to $55.81, totaling $1,581,994. Following these transactions, Cheng directly owns 686,062 shares of Akero Therapeutics.

SEC Filing: [Akero Therapeutics, Inc. [ AKRO ] - Form 4 - Feb. 11, 2025](https://www.sec.gov/Archives/edgar/data/1778307/000095017025018311/xslF345X05/ownership.xml)

[TradingView](https://www.tradingview.com/news/tradingview:61dc02d5462e6:0-akero-therapeutics-ceo-cheng-andrew-sells-30-000-shares/)
